A. D. Beadell Investment Counsel Inc. boosted its position in Stericycle Inc (NASDAQ:SRCL) by 8.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,225 shares of the business services provider’s stock after buying an additional 930 shares during the period. A. D. Beadell Investment Counsel Inc.’s holdings in Stericycle were worth $1,013,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently modified their holdings of the company. Capital Analysts LLC raised its position in shares of Stericycle by 6.2% in the fourth quarter. Capital Analysts LLC now owns 1,294 shares of the business services provider’s stock worth $100,000 after buying an additional 76 shares during the period. Pacad Investment Ltd. purchased a new position in shares of Stericycle during the fourth quarter worth about $100,000. Fuller & Thaler Asset Management Inc. purchased a new position in shares of Stericycle during the third quarter worth about $136,000. Parallel Advisors LLC purchased a new position in shares of Stericycle during the fourth quarter worth about $140,000. Finally, JNBA Financial Advisors raised its position in shares of Stericycle by 733.3% in the fourth quarter. JNBA Financial Advisors now owns 1,950 shares of the business services provider’s stock worth $150,000 after buying an additional 1,716 shares during the period. Institutional investors own 94.49% of the company’s stock.
Shares of Stericycle Inc (NASDAQ:SRCL) opened at 83.56 on Friday. Stericycle Inc has a 12-month low of $71.52 and a 12-month high of $107.74. The company has a 50-day moving average price of $84.22 and a 200 day moving average price of $79.75. The firm has a market capitalization of $7.12 billion, a PE ratio of 43.54 and a beta of 0.08.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, May 4th. The business services provider reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The firm had revenue of $892.40 million for the quarter, compared to analyst estimates of $874.34 million. During the same quarter in the prior year, the firm earned $1.11 EPS. The company’s revenue was up 2.1% on a year-over-year basis. On average, equities analysts expect that Stericycle Inc will post $4.63 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “A. D. Beadell Investment Counsel Inc. Acquires 930 Shares of Stericycle Inc (SRCL)” was published by BBNS and is the property of of BBNS. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://baseballnewssource.com/markets/stericycle-inc-srcl-shares-bought-by-a-d-beadell-investment-counsel-inc-updated-updated-updated/638199.html.
A number of research firms have weighed in on SRCL. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research note on Saturday, May 6th. Zacks Investment Research upgraded Stericycle from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research note on Tuesday, April 25th. Barrington Research lifted their price objective on Stericycle from $84.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, February 22nd. Robert W. Baird lowered Stericycle from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $74.00 to $73.00 in a research note on Friday, May 5th. Finally, Raymond James Financial, Inc. restated a “market perform” rating on shares of Stericycle in a research note on Monday, February 20th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. Stericycle has an average rating of “Hold” and a consensus target price of $82.17.
In related news, Director Mike S. Zafirovski acquired 2,920 shares of the firm’s stock in a transaction on Thursday, February 23rd. The shares were purchased at an average price of $85.67 per share, with a total value of $250,156.40. Following the acquisition, the director now directly owns 2,920 shares in the company, valued at $250,156.40. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 3.30% of the stock is owned by corporate insiders.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc and related companies with our FREE daily email newsletter.